Tzvi Palash
2013
In 2013, Tzvi Palash earned a total compensation of $604.7K as Chief Operating Officer at Protalix BioTherapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Option Awards | $72,055 |
| Salary | $231,668 |
| Stock Awards | $208,822 |
| Other | $72,105 |
| Total | $604,650 |
Palash received $231.7K in salary, accounting for 38% of the total pay in 2013.
Palash also received $20K in bonus, $72.1K in option awards, $208.8K in stock awards and $72.1K in other compensation.
Rankings
In 2013, Tzvi Palash's compensation ranked 8,691st out of 12,286 executives tracked by ExecPay. In other words, Palash earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,691 out of 12,286 | 29th |
Division Manufacturing | 3,158 out of 4,612 | 32nd |
Major group Chemicals And Allied Products | 999 out of 1,462 | 32nd |
Industry group Drugs | 759 out of 1,156 | 34th |
Industry Biological Products, Except Diagnostic Substances | 122 out of 196 | 38th |
Source: SEC filing on July 1, 2016.
Palash's colleagues
We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2013.
2013
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2013
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2013
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2013
Einat Almon
Protalix BioTherapeutics